Chapter 22 Peripheral neuropathies in human immunodeficiency virus infection

Supplements to Clinical Neurophysiology

Volumn 57, Issue C, 2004, Pages 195-210

  Höke, Ahmet ^a   Cornblath, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOLOGY; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; REVIEW; VIROLOGY;

ANIMALS; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES;

EID: 25144456460     PISSN: 1567424X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-424X(09)70358-7     Document Type: Article

References (158)

1. Alliegro M.B., et al. Peripheral neuropathies among patients with HIV infection. J. Neurol. Neurosurg. Psychiatry 64 (1998) 414-415
2. Anders H.J., Weiss N., Bogner J.R., and Goebel F.D. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J. Infect. 36 (1998) 29-33
3. Anderson T.D., et al. Peripheral neuropathy induced by 2′,3′-dideoxycytidine. A rabbit model of 2′,3′-dideoxycytidine neurotoxicity. Lab. Invest. 66 (1992) 63-74
4. Anderson T.D., et al. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Lab. Invest. 70 (1994) 724-739
5. Anonymous. Testing for neurological involvement in HIV infection. Lancer 2 (1987) 1531-1532
6. Authier F.J., and Gheradi R.K. Peripheral neuropathies in HIV-infected patients in the era of HAART. Brain Pathol. 13 (2003) 223-228
7. Autran B., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277 (1997) 112-116
8. Bacellar H., et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 44 (1994) 1892-1900
9. Bailey R.O., Baltch A.L., Venkatesh R., Singh J.K., and Bishop M.B. Sensory motor neuropathy associated with AIDS. Neurology 38 (1988) 886-891
10. Behar R., Wiley C., and McCutchan J.A. Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology 37 (1987) 557-561
11. Belec L., et al. Peripheral facial paralysis and HIV infection: report of four African cases and review of the literature. J. Neurol. 236 (1989) 411-414
12. Berger J.R., Difini J.A., Swerdloff M.A., and Ayyar D.R. HIV seropositivity in Guillain-Barré syndrome. Ann. Neurol. 22 (1987) 393-394
13. Berger A.R., et al. 2′,3′-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 43 (1993) 358-362
14. Bishopric G., Bruner J., and Butler J. Guillain-Barré syndrome with cytomegalovirus infection of peripheral nerves. Arch. Pathol. Lab. Med. 109 (1985) 1106-1108
15. Blum A.S., et al. Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors. Neurology 46 (1996) 999-1003
16. Bozzette S.A., and Richman D.D. Salvage therapy for zidovudine-intolerant HIV-infected patients with alternating and intermittent regimens of zidovudine and dideoxycytidine. Am. J. Med. 88 (1990) 24S-26S
17. Brannagan III T.H., Nuovo G.J., Hays A.P., and Latov N. Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization. Ann. Neurol. 42 (1997) 368-372
18. Brannagan III T.H., and Zhou Y. HIV-associated Guillain-Barré syndrome. J. Neurol. Sci. 208 (2003) 39-42
19. Breen R.A., Lipman M.C., and Johnson M.A. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. Aids 14 (2000) 615
20. Brew B.J., Tisch S., and Law M. Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy. Aids 17 (2003) 1094-1096
21. Calabrese L.H., Profitt M.R., Levin K.H., Yen-Lieberman B., and Starkey C. Acute infection with the human immunodeficiency virus (HIV) associated with acute brachial neuritis and exanthematous rash. Ann. Intern. Med. 107 (1987) 849-851
22. Carne C.A., et al. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet 2 (1985) 1206-1208
23. Chavanet P.Y., et al. Altered peripheral nerve conduction in HIV-patients. Cancer Detect. Prev. 12 (1988) 249-255
24. Chavanet P., et al. Infraclinical neuropathies related to immunodeficiency virus infection associated with higher T-helper cell count. J. Acquir. Immune Defic. Syndr. 2 (1989) 564-569
25. Cherry C.L., et al. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J. Acquir. Immune Defic. Syndr. 30 (2002) 271-277
26. Cherry C.L., McArthur J.C., Hoy J.F., and Wesselingh S.L. Nucleoside analogues and neuropathy in the era of HAART. J. Clin. Virol. 26 (2003) 195-207
27. Chen C.H., Vazquez-Padua M., and Cheng Y.C. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol. Pharmacol. 39 (1991) 625-628
28. Childs E.A., et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52 (1999) 607-613
29. Conlon C.P. HIV infection presenting as Guillain-Barré syndrome in Lusaka, Zambia. Trans. R. Soc. Trop. Med. Hyg. 83 (1989) 109
30. Cooley T.P., et al. Once-daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N. Engl. J. Med. 322 (1990) 1340-1345
31. Cooper D.A., et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet 1 (1985) 537-540
32. Cornblath D.R., and McArthur J.C. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 38 (1988) 794-796
33. Cornblath D.R., McArthur J.C., Kennedy P.G., Witte A.S., and Griffin J.W. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann. Neurol. 21 (1987) 32-40
34. Cornblath D.R., et al. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann. Neurol. 23 (1988) 354-359
35. Crane L.R., and Ebright J.R. Cytomegalovirus polyradiculopathy caused by a ganciclovir-resistant strain. Clin. Infect. Dis. 19 (1994) 365
36. Cruz Martinez A., and Villoslada C. Electrophysiologic study in peripheral neuropathy associated with HIV infection. Electromyogr. Clin. Neurophysiol. 31 (1991) 407-414
37. Cupps T.R., and Fauci A.S. The vasculitides (1981), W.B. Saunders, Philadelphia
38. Dalakas M.C., and Pezeshkpour G.H. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann. Neurol. 23 Suppl. (1988) S38-S48
39. De la Monte S.M., et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann. Neurol. 23 (1988) 485-492
40. Decker C.F., Tarver III J.H., Murray D.F., and Martin G.J. Prolonged concurrent use of ganciclovir and foscarnet in the treatment of polyradiculopathy due to cytomegalovirus in a patient with AIDS. Clin. Infect. Dis. 19 (1994) 548-549
41. Denning D.W. The neurological features of acute HIV infection. Biomed. Pharmacother. 42 (1988) 11-14
42. Denning D.W., Anderson J., Rudge P., and Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br. Med. J. (Clin. Res. Ed.) 294 (1987) 143-144
43. Dubinsky R.M., Yarchoan R., Dalakas M., and Broder S. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2′,3′-dideoxycytidine (ddC). Muscle Nerve 12 (1989) 856-860
44. Dyck P.J., et al. Nonsystemic vasculitic neuropathy. Brain 110 (1987) 843-853 Pt. 4
45. Eidelberg D., et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 36 (1986) 912-916
46. Evenhouse M., et al. Hypotension in infection with the human immunodeficiency virus. Ann. Intern. Med. 107 (1987) 598-599
47. Feldman D., Brosnan C., and Anderson T.D. Ultrastructure of peripheral neuropathy induced in rabbits by 2′,3′-dideoxycytidine. Lab. Invest. 66 (1992) 75-85
48. Fialho D., and Cornblath D.R. Treatment for human immunodeficiency virus-related distal symmetric polyneuropathy (Protocol for a Cochrane Review). Cochrane Database Syst. Rev. (2003)
49. Fichtenbaum C.J., Clifford D.B., and Powderly W.G. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. Hum. Retroviral. 10 (1995) 169-174
50. Franco-Paredes C., Rebolledo P., Folch E., Hernandez I., and del Rio C. Diagnosis of diffuse CD8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read. 12 (2002) 408-413
51. French M., et al. Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study. HIV Clin. Trials 3 (2002) 177-185
52. Fuller G.N., et al. Ganciclovir for lumbosacral polyradiculopathy in AIDS. Lancet 335 (1990) 48-49
53. Fuller G.N., Greco C.M., and Miller R.G. Cytomegalovirus and mononeuropathy multiplex in AIDS. Neurology 40 (1990) 301
54. Fuller G.N., Jacobs J.M., and Guiloff R.J. Nature and incidence of peripheral nerve syndromes in HIV infection. J. Neurol. Neurosurg. Psychiatry 56 (1993) 372-381
55. Gastaut J.L., Gastaut J.A., Pellissier J.F., Tapko J.B., and Weill O. Peripheral neuropathies in human immunodeficiency virus infection. A prospective study of 56 patients. Rev. Neurol. (Paris) 145 (1989) 451-459
56. Gendelman, H.E., Epstein, L. and Swindels, S. Chapman and Hall, New York, 1998, 275-291.
57. Gherardi R., et al. Necrotizing vasculitis and HIV replication in peripheral nerves. N. Engl. J. Med. 321 (1989) 685-686
58. Gherardi R.K., et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 50 (1998) 1041-1044
59. Grafe M.R., and Wiley C.A. Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann. Neurol. 25 (1989) 561-566
60. Graveleau P., Perol R., and Chapman A. Regression of cauda equina syndrome in AIDS patient being treated with ganciclovir. Lancet 2 (1989) 511-512
61. Griffin D.W., and McArthur J.C. Am. J. Med. 82 (1987) 655-661 Peripheral neuropathies associated with HIV infection Guillon, J.M. et al. (Eds.), The Neurology of AIDS Extensive T8-positive lymphocytic visceral infiltration in a homosexual man
62. Hagberg L., Malmvall B.E., Svennerholm L., Alestig K., and Norkrans G. Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. Scand. J. Infect. Dis. 18 (1986) 591-592
63. Hall C.D., et al. Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients. Incidence and relationship to other nervous system dysfunction. Arch. Neurol. 48 (1991) 1273-1274
64. Ho D.D., et al. Primary human T-lymphotropic virus type III infection. Ann. Intern. Med. 103 (1985) 880-883
65. Ho D.D., et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med. 313 (1985) 1493-1497
66. Hoke A., Keswani S.C., and McArthur J. Current Therapy for HIV Sensory Neuropathy. Curr. Treat. Op. Infect. Dis. 5 (2003) 467-475
67. Hughes R.A., Raphael J.C., Swan A.V., and Van Doorn P.A. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst. Rev. (2003)
68. Itescu S., and Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis. Clin. North Am. 18 (1992) 683-697
69. Itescu S., Brancato L.J., and Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 2 (1989) 466-468
70. Jacobson M.A., et al. Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis. Arch. Neurol. 45 (1988) 1090-1092
71. Kazi S., Cohen P.R., Williams F., Schempp R., and Reveille J.D. The diffuse infiltrative lymphocytosis syndrome. Clinical and immunogenetic features in 35 patients. Aids 10 (1996) 385-391
72. Keilbaugh S.A., Prusoff W.H., and Simpson M.V. The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs. Biochem. Pharmacol. 42 (1991) R5-R8
73. Keswani S.C., Pardo C.A., Cherry C.L., Hoke A., and McArthur J.C. HIV-associated sensory neuropathies. Aids 16 (2002) 2105-2117
74. Keswani S.C., et al. Chemokine receptors on Schwann cells mediate HIV-1 gp120 toxicity to sensory neurons. Ann. Neurol. 54 (2003) 287-296
75. Keswani S.C., et al. FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. Ann. Neurol. 53 (2003) 57-64
76. Kim Y.S., and Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin. Infect. Dis. 17 (1993) 32-37
77. Kissel J.T., Riethman J.L., Omerza J., Rammohan K.W., and Mendell J.R. Peripheral nerve vasculitis: immune characterization of the vascular lesions. Ann. Neurol. 25 (1989) 291-297
78. La Spina I., Porazzi D., Maggiolo F., Bottura P., and Suter F. Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations. Eur. J. Neurol. 8 (2001) 71-75
79. Lambert J.S., et al. 2′,3′-dideoxyinosine (ddl) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. N. Engl. J. Med. 322 (1990) 1333-1340
80. Lange D.J., Britton C.B., Younger D.S., and Hays A.P. The neuromuscular manifestations of human immunodeficiency virus infections. Arch. Neural. 45 (1988) 1084-1088
81. Lanska M.J., Lanska D.J., and Schmidley J.W. Syphilitic polyradiculopathy in an HIV-positive man. Neurology 38 (1988) 1297-1301
82. Leger J.M., et al. The peripheral nervous system and HIV infection. 13 cases. Rev. Neurol. (Paris) 144 (1988) 789-795
83. Leger J.M., et al. The spectrum of polyneuropathies in patients infected with HIV. J. Neurol. Neurosurg. Psychiatry 52 (1989) 1369-1374
84. LeLacheur S.F., and Simon G.L. Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine. J. Acquir. Immune Defic. Syndr. 4 (1991) 538-539
85. Leport C., et al. (Peripheral neuropathy in relation to LAV/HTLV III retrovirus infection. A clinical, anatomical and immunological study. 5 cases). Presse. Med. 16 (1987) 55-58
86. Levy R.M., Bredesen D.E., and Rosenblum M.L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J. Neurosurg. 62 (1985) 475-495
87. Lipkin W.I., Parry G., Kiprov D., and Abrams D. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 35 (1985) 1479-1483
88. Lin-Greenberg A., and Taneja-Uppal N. Dysautonomia and infection with the human immunodeficiency virus. Ann. Intern. Med. 106 (1987) 167
89. Lohmoller G., Matuschke A., and Goebel F.D. False-positive test of autonomic neuropathy in HIV infection and AIDS? Case control study of heart rate variability in 62 HIV positive patients. Med. Klin. 84 (1989) 242-245
90. Luciano C.A., Pardo C.A., and McArthur J.C. Recent developments in the HIV neuropathies. Curr. Opin. Neurol. 16 (2003) 403-409
91. Mahadevan A., et al. Vasculitic neuropathy in HIV infection: a clinicopathological study. Neurol. India 49 (2001) 277-283
92. Miller R.F., and Semple S.J. Autonomic neuropathy in AIDS. Lancet 2 (1987) 343-344
93. Mahieux F., et al. Acute myeloradiculitis due to cytomegalovirus as the initial manifestation of AIDS. J. Neurol. Neurosurg. Psychiatry 52 (1989) 270-274
94. McArthur J.C., et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 54 (2000) 1080-1088
95. McDougal J.S., et al. Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J. Clin. Immunol. 5 (1985) 130-138
96. Mehndiratta M.M., and Hughes R.A. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev (2003)
97. Mehndiratta M.M., Hughes R.A., and Agarwal P. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev (2003)
98. Mendell J.R., and Sahenk Z. Clinical practice. Painful sensory neuropathy. N. Engl. J. Med. 348 (2003) 1243-1255
99. Meng T.C., Fischl M.A., and Richman D.D. AIDS Clinical Trials Group: phase I/II study of combination 2′,3′-dideoxycytidine and zidovudine in patients with acquired immunodeficiency syndrome (AIDS) and advanced AIDS-related complex. Am. J. Med. 88 (1990) 27S-30S
100. Merigan T.C., and Skowron G. Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. Am. J. Med. 88 (1990) 11S-15S
101. Merigan T.C., et al. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study. Ann. Intern. Med. 110 (1989) 189-194
102. Miller R.G., et al. The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 11 (1988) 857-863
103. Miller R.G., Storey J.R., and Greco C.M. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 40 (1990) 569-574
104. Milligan E.D., et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 861 (2000) 105-116
105. Milligan E.D., et al. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J. Neurosci. 21 (2001) 2808-2819
106. Moore R.D., Wong W.M., Keruly J.C., and McArthur J.C. Incidence of neuropathy in HIV-infected patients on monotherapy vs. those on combination therapy with didanosine, stavudine and hydroxyurea. Aids 14 (2000) 273-278
107. Moskowitz L.B., Gregorios J.B., Hensley G.T., and Berger J.R. Cytomegalovirus. Induced demyelination associated with acquired immune deficiency syndrome. Arch. Pathol. Lab. Med. 108 (1984) 873-877
108. Moulignier A., et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann. Neurol. 41 (1997) 438-445
109. Mouton Y., et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres DeLutte contre le SIDA. Aids 11 (1997) F101-F105
110. Moyle G. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. Clin. Ther. 22 (2000) 911-936 discussion 898
111. Murray H.W., et al. Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089. J. Infect. Dis. 171 Suppl. 2 (1995) S123-S130
112. Newshan G. HIV neuropathy treated with gabapentin. Aids 12 (1998) 219-221
113. Oh S.B., et al. Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 21 (2001) 5027-5035
114. Paice J.A., et al. Topical capsaicin in the management of HIV-associated peripheral neuropathy. J. Pain Symptom. Manage. 19 (2000) 45-52
115. Pardo C.A., McArthur J.C., and Griffin J.W. HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J. Peripher. Nerv. Syst. 6 (2001) 21-27
116. Parry G.J. Peripheral neuropathies associated with human immunodeficiency virus infection. Ann. Neurol. 23 Suppl. (1988) S49-S53
117. Periquet M.I., et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 53 (1999) 1641-1647
118. Persuy P., et al. (Guillain-Barré syndrome with favorable outcome in a case of recent human immunodeficiency virus infection). Rev. Neurol. (Paris) 144 (1988) 32-35
119. Piette A.M., et al. Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet 1 (1986) 852
120. Pizzo P.A. Treatment of human immunodeficiency virus-infected infants and young children with dideoxynucleosides. Am. J. Med. 88 (1990) 16S-19S
121. Polydefkis M., et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58 (2002) 115-119
122. Przedborski S., et al. Inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection. J. Neurol. 235 (1988) 359-361
123. Rance N.E., et al. Gracile tract degeneration in patients with sensory neuropathy and AIDS. Neurology 38 (1988) 265-271
124. Raphael J.C., Chevret S., Hughes R.A., and Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst. Rev. (2003)
125. Rathbun R.C., and Martin E.S. 3rd. Didanosine therapy in patients intolerant of or failing zidovudine therapy. Ann. Pharmacother. 26 (1992) 1347-1351
126. Rizzuto N., et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol. (Berl.) 90 (1995) 244-250
127. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol. 8 Suppl. 2 (2002) 115-121
128. Said G., Lacroix C., and Andrieu J.N. Necrotizing arteritis in patients with inflammatory neuropathy and human immunodeficiency virus (HIV-III) infection. Neurology 37 (1987) 176
129. Said G., Lacroix-Ciaudo C., Fujimura H., Blas C., and Faux N. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann. Neurol. 23 (1988) 461-465
130. Schaumberg H.H., Spencer P.S., and Thomas P.K. Disorders of Peripheral Nerves (1983), FA Davis, Philadelphia
131. Schifitto G., et al. Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 58 (2002) 1764-1768
132. Shlay J.C., et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. Jama 280 (1998) 1590-1595
133. Simpson D.M. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J. Neurovirol. 8 Suppl. 2 (2002) 33-41
134. Simpson D.M., and Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9 (1995) 153-161
135. Simpson D.M., et al. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology 54 (2000) 2115-2119
136. Simpson D.M., et al. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. Aids 16 (2002) 407-412
137. Simpson D.M., et al. Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial. Neurology 60 (2003) 1508-1514
138. Skowron G. Biologic effects and safety of stavudine: overview of phase I and II clinical trials. J. Infect. Dis. 171 Suppl. 2 (1995) S113-S117
139. So Y.T., and Olney R.K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann. Neurol. 35 (1994) 53-58
140. Smith K.M., Crandall K.A., Kneissl M.L., and Navia B.A. PCR detection of host and HIV-1 sequences from archival brain tissue. J. Neurovirol. 6 (2000) 164-171
141. Smith I.L., Shinkai M., Freeman W.R., and Spector S.A. Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates. J. Infect. Dis. 173 (1996) 1481-1484
142. Starnes M.C., and Cheng Y.C. Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J. Biol. Chem. 262 (1987) 988-991
143. Thornton C.A., Latif A.S., and Emmanuel J.C. Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology 41 (1991) 812-815
144. Tokumoto J.I., and Hollander H. Cytomegalovirus polyradiculopathy caused by a gancielovir-resistant strain. Clin. Infect. Dis. 17 (1993) 854-856
145. Tucker T., Dix R.D., Katzen C., Davis R.L., and Schmidley J.W. Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome. Ann. Neurol. 18 (1985) 74-79
146. Van Schaik I.N., Winer J.B., DeHaan R., and Vermeulen M. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst. Rev. (2003)
147. Vendrell J., et al. Guillain-Barré syndrome associated with seroconversion for anti-HTLV-III. Neurology 37 (1987) 544
148. Villa A., Foresti V., and Confalonieri F. Autonomic neuropathy and HIV infection. Lancet 2 (1987) 915
149. Villa A., Foresti V., and Confalonieri F. Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. Aids 6 (1992) 85-89
150. Villa A., Foresti V., and Confalonieri F. Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin. Auton. Res. 5 (1995) 48-52
151. Walsh C.M., Nardi M.A., and Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N. Engl. J. Med. 311 (1984) 635-639
152. Wechsler A.F., and Ho D.D. Bilateral Bell's palsy at the time of HIV seroconversion. Neurology 39 (1989) 747-748
153. Wiley C.A. Neuromuscular diseases of AIDS. Faseb. J. 3 (1989) 2503-2511
154. Williams D., Geraci A., and Simpsona D.D. AIDS and AIDS-treatment neuropathies. Curr. Pain Headache Rep. 6 (2002) 125-130
155. Winer J.B., et al. A study of neuropathy in HIV infection. Q. J. Med. 83 (1992) 473-488
156. Wiselka M.J., Nicholson K.G., Ward S.C., and Flower A.J. Acute infection with human immunodeficiency virus associated with facial nerve palsy and neuralgia. J. Infect. 15 (1987) 189-190
157. Yarchoan R., et al. Phase I studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet 1 (1988) 76-81
158. Yoshioka M., et al. Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 44 (1994) 1120-1130